Holen Sie sich die Stockscreener-App
13.33
1.34%
0.24
Korro Bio Inc Aktie (KRRO) Neueste Nachrichten
Korro Bio, Inc. (NASDAQ:KRRO) Shares Acquired by California State Teachers Retirement System - Defense World
Cantor Fitzgerald Estimates Korro Bio FY2026 Earnings - Defense World
Wellington Management Group LLP Raises Stock Holdings in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Nuveen Asset Management LLC Purchases 17,131 Shares of Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Jane Street Group LLC Makes New Investment in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Deutsche Bank AG Buys 935 Shares of Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of “Buy” from Analysts - Defense World
KRRO stock touches 52-week low at $11.06 amid sharp annual decline By Investing.com - Investing.com South Africa
KRRO stock touches 52-week low at $11.06 amid sharp annual decline - Investing.com Nigeria
Korro Bio, Inc. (NASDAQ:KRRO) Shares Purchased by BNP Paribas Financial Markets - Defense World
Korro Bio’s SWOT analysis: RNA editing pioneer’s stock faces pivotal year By Investing.com - Investing.com South Africa
Korro Bio’s SWOT analysis: RNA editing pioneer’s stock faces pivotal year - Investing.com India
Korro Bio, Inc. (NASDAQ:KRRO) Stock Position Boosted by Northern Trust Corp - Defense World
Finance Watch: Prime, Kyverna, Allogene And More Announce Job Cuts - insights.citeline.com
Brokers Offer Predictions for Korro Bio FY2025 Earnings - Defense World
Balyasny Asset Management L.P. Makes New Investment in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Korro to Participate in Upcoming Investor Conferences - The Manila Times
Korro Bio Leadership Takes Stage at Three Major Healthcare Conferences: RBC, Jefferies, and Goldman Sachs - Stock Titan
Korro Bio (KRRO) Rating and Price Target Maintained by Chardan C - GuruFocus
Oppenheimer Adjusts Price Target for Korro Bio (KRRO) Amid Secto - GuruFocus
Oppenheimer Lowers Price Target for Korro Bio (KRRO) But Maintai - GuruFocus
Oppenheimer Lowers Price Target for Korro Bio (KRRO) But Maintains Rating | KRRO Stock News - GuruFocus
Oppenheimer Adjusts Korro Bio Price Target to $90 From $155, Maintains Outperform Rating - marketscreener.com
Korro Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Korro Bio FY2025 EPS Estimate Raised by Cantor Fitzgerald - Defense World
Q2 Earnings Estimate for Korro Bio Issued By William Blair - Defense World
Q2 Earnings Forecast for Korro Bio Issued By HC Wainwright - Defense World
HC Wainwright Cuts Korro Bio (NASDAQ:KRRO) Price Target to $100.00 - Defense World
HC Wainwright Comments on Korro Bio FY2026 Earnings - Defense World
Wells Fargo & Company MN Raises Holdings in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
10,384 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Purchased by Barclays PLC - Defense World
10,347 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Acquired by Raymond James Financial Inc. - Defense World
Korro Bio (KRRO) Price Target Cut Amid Strategic Adjustments | K - GuruFocus
Korro Bio price target lowered to $53 from $130 at H.C. Wainwright - Yahoo Finance
Korro Bio Reports Q1 2025 Financial Results - TipRanks
Korro Bio, Inc. (NASDAQ:KRRO) Given Average Rating of “Buy” by Analysts - Defense World
Korro Bio stock price target lowered to $100 at H.C. Wainwright By Investing.com - Investing.com South Africa
Korro Bio stock price target lowered to $100 at H.C. Wainwright - Investing.com Nigeria
4 more biotechs cut staff amid market tumult - BioPharma Dive
ALX Oncology won’t seek approval for CD47 drug in gastric cancer; Korro Bio’s layoffs - Endpoints News
Korro lays off 20% of staff to fund genetic med trials, Novo Nordisk partnership - Fierce Biotech
Korro Bio (KRRO) Analyst Rating Update: Price Target Lowered | K - GuruFocus
Korro Bio (KRRO) Price Target Reduced, Buy Rating Maintained | K - GuruFocus
Korro Reports First Quarter 2025 Financial Results and Provides Business Updates - The Manila Times
Korro (KRRO) Surpasses Q1 Revenue Expectations Amid Promising Cl - GuruFocus
Korro Bio Announces Strategic Workforce Reduction Plan - TipRanks
Korro Bio, Inc. SEC 10-Q Report - TradingView
Korro Bio, Inc. Reports Q1 2025 Financial Results and Updates on KRRO-110 Development for Alpha-1 Antitrypsin Deficiency - Nasdaq
JPMorgan Chase & Co. Sells 9,537 Shares of Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Legal & General Group Plc Raises Stock Holdings in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Analysts Offer Predictions for Korro Bio FY2025 Earnings - Defense World
Cantor Fitzgerald Upgrades Korro Bio (NASDAQ:KRRO) to Strong-Buy - Defense World
Cantor Fitzgerald sets $74 target on Korro Bio stock with Overweight rating - Investing.com India
0.34%
7.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):